Results 31 to 40 of about 3,630,045 (162)
Xeloda as first-line therapy of metastatic colorectal cancer-our experience [PDF]
BACKGROUND: Results of phase III clinical studies comparing efficacy of Xeloda vs. standard 5-FU/FA protocols as first line therapy of metastatic colorectal carcinoma (MCRC), have shown better efficacy of Xeloda, with less toxic adverse effects, apart ...
Kovčin Vladimir +4 more
doaj +1 more source
The definition of antineoplastic administration sequences can help planning of therapeutic regimens in a more rational way, and thus optimize chemotherapy effects on patients, increasing efficacy and reducing toxic effects.
Juliane Carlotto (5380121) +2 more
core +1 more source
Compliance with a protocol for acute lymphoblastic leukemia in childhood
BACKGROUND: Remission rates achieved after the initial treatment of acute lymphoblastic leukemia may be similar in both developed and developing countries, but relapse rates are much higher in the latter.
Benigna Maria de Oliveira +3 more
doaj +1 more source
Nurse Safety in the Management of Antineoplastic Therapy: Scoping Review
Objetivo Identify and synthesize the scientific evidence on cancer nurse safety in the management of antineoplastic therapy. Question Formulation P (Population) – Oncology Nursing. C (Concept) – Occupational Safety. C (Context) – Antineoplastic Agents.
Patrícia Peres de Oliveira +2 more
core +2 more sources
The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R‐CHOP) is the first‐line treatment for non‐Hodgkin lymphoma (NHL).
Rong Han +6 more
doaj +1 more source
OBJECTIVE: To evaluate viral vaccine antibody levels in children with acute lymphoblastic leukemia after chemotherapy and after vaccine booster doses.
Simone Santana Viana +5 more
doaj +1 more source
Representation and comparison of chemotherapy protocols with ChemoKG and graph embeddings
International audienceBackground: Chemotherapy, a central cancer treatment, employs antineoplastic drugs to hinder cancer cell replication by disrupting DNA synthesis or mitosis.
Sabatier, Brigitte +6 more
core +3 more sources
Background: The treatment of multiple myeloma (MM) has evolved significantly in the past decade, and new drug combinations have improved the response rates and prolonged survival.
Edvan De Queiroz Crusoe +23 more
doaj +1 more source
Complete blood count evaluation of dogs: four chemotherapy protocols
This retrospective study aimed to evaluate potential hematological alterations in dogs treated with four different antineoplastic ...
Lucas Kluthcovsky (6611507)
core +1 more source
International audienceBackground: Malignancies are a major cause of late death after liver transplantation (LT). In LT recipients presenting a malignancy, antineoplastic chemotherapy is central part of the therapeutic arsenal, but management of both ...
Coupier, Antoine +17 more
core +1 more source

